Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin (1-7) for COVID-19
NCT04570501Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Feb 2022
- Primary completion
- Aug 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of angiotensin-(1-7) in coronavirus disease 2019 (COVID-19), sponsored by Stanford University. Planned start Feb 2022; status: withdrawn.
02
Drugs
angiotensin-(1-7)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04570501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04570501.